Literature DB >> 16503444

Atenolol and cardiovascular risk: an issue close to the heart.

Ian B Wilkinson1, Carmel M McEniery, John R Cockcroft.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16503444     DOI： 10.1016/S0140-6736(06)68238-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  The latest generation of beta-blockers: new pharmacologic properties.

Authors:  Michala E Pedersen; John R Cockcroft
Journal:  Curr Hypertens Rep       Date:  2006-08       Impact factor: 5.369

Review 2.  The vasodilatory beta-blockers.

Authors:  Michala E Pedersen; John R Cockcroft
Journal:  Curr Hypertens Rep       Date:  2007-08       Impact factor: 5.369

Review 3.  Nebivolol: a review of its use in the management of hypertension and chronic heart failure.

Authors:  Marit D Moen; Antona J Wagstaff
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  Cardiac oxygen supply is compromised during the night in hypertensive patients.

Authors:  Berend E Westerhof; Johannes J van Lieshout; Gianfranco Parati; Gert A van Montfrans; Ilja Guelen; Jos A E Spaan; Nico Westerhof; John M Karemaker; Willem Jan W Bos
Journal:  Med Biol Eng Comput       Date:  2011-07-23       Impact factor: 2.602

Review 5.  Does it matter where we measure blood pressure?

Authors:  Laurie A Tomlinson; Ian B Wilkinson
Journal:  Br J Clin Pharmacol       Date:  2012-08       Impact factor: 4.335

6.  Update on beta-blockers in hypertension.

Authors:  Debbie L Cohen; Raymond R Townsend
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-12       Impact factor: 3.738

Review 7.  Central blood pressure: current evidence and clinical importance.

Authors:  Carmel M McEniery; John R Cockcroft; Mary J Roman; Stanley S Franklin; Ian B Wilkinson
Journal:  Eur Heart J       Date:  2014-01-23       Impact factor: 29.983

8.  Determination of aortic pulse transit time based on waveform decomposition of radial pressure wave.

Authors:  Wenyan Liu; Daiyuan Song; Yang Yao; Lin Qi; Liling Hao; Jun Yang; Hongxia Ning; Lisheng Xu
Journal:  Sci Rep       Date:  2021-10-11       Impact factor: 4.379

9.  Does atenolol differ from other beta-adrenergic blockers?

Authors:  Ivar Aursnes; Jan-Bjørn Osnes; Ingunn Fride Tvete; Jørund Gåsemyr; Bent Natvig
Journal:  BMC Clin Pharmacol       Date:  2007-05-08

Review 10.  A review of the safety and efficacy of nebivolol in the mildly hypertensive patient.

Authors:  John Cockcroft
Journal:  Vasc Health Risk Manag       Date:  2007
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.